Daiwa Securities Group
MDGL icon

Daiwa Securities Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Daiwa Securities Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
747
-20
-3% -$10.2K ﹤0.01% 1004
2026
Q1 		$402K Buy
767
+699
+1,028% +$334K ﹤0.01% 946
2025
Q4 		$40K Sell
68
-2
-3% -$1.02K ﹤0.01% 1132
2025
Q3 		$32K Sell
70
-7
-9% -$2.61K ﹤0.01% 1118
2025
Q2 		$23K Buy
77
+5
+7% +$1.49K ﹤0.01% 1095
2025
Q1 		$24K Hold
72
– – ﹤0.01% 1065
2024
Q4 		$22K Sell
72
-11
-13% -$3.09K ﹤0.01% 1084
2024
Q3 		$18K Buy
83
+9
+12% +$2.3K ﹤0.01% 1104
2024
Q2 		$21K Hold
74
– – ﹤0.01% 1132
2024
Q1 		$20K Sell
74
-7
-9% -$1.65K ﹤0.01% 1137
2023
Q4 		$19K Buy
81
+12
+17% +$2.1K ﹤0.01% 1130
2023
Q3 		$10K Hold
69
– – ﹤0.01% 1125
2023
Q2 		$16K Hold
69
– – ﹤0.01% 1114
2023
Q1 		$17K Hold
69
– – ﹤0.01% 1084
2022
Q4 		$20K Buy
69
+12
+21% +$1.17K ﹤0.01% 1082
2022
Q3 		$4K Hold
57
– – ﹤0.01% 1177
2022
Q2 		$4K Hold
57
– – ﹤0.01% 1184
2022
Q1 		$6K Hold
57
– – ﹤0.01% 1161
2021
Q4 		$5K Hold
57
– – ﹤0.01% 1200
2021
Q3 		$5K Buy
57
+28
+97% +$2.42K ﹤0.01% 1177
2021
Q2 		$3K Hold
29
– – ﹤0.01% 1112
2021
Q1 		$3K Hold
29
– – ﹤0.01% 1111
2020
Q4 		$3K Buy
+29
New +$3.54K ﹤0.01% 1090

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Daiwa Securities Group's MDGL Position: Q2 2026 in Review

Daiwa Securities Group reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.6% in Q2 2026, selling an estimated $10.2K and leaving 747 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Daiwa Securities Group first reported a position in MDGL in Q4 2020 and has held it in 23 quarters since. The position peaked at $402K in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Daiwa Securities Group held 747 shares of Madrigal Pharmaceuticals worth $401K as of Q2 2026.
  • Daiwa Securities Group sold 20 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #1004 holding.
  • Daiwa Securities Group first reported a position in Madrigal Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Daiwa Securities Group's Madrigal Pharmaceuticals position peaked at $402K in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.